| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | France | 3 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Foods and drinks |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Peptides | |
| #4 | Microorganisms | |
| #5 | Enzymes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Jacotot Etienne | 10 |
| #2 | Rebouillat Dominique | 8 |
| #3 | Chauvier David | 6 |
| #4 | Borgne Annie | 5 |
| #5 | Casimir Richard | 2 |
| #6 | Langonne Alain | 2 |
| #7 | Lecoeur Herve | 2 |
| #8 | Dupont Sylvie | 2 |
| #9 | Borgne Sanchez Annie | 1 |
| #10 | Hoebeke Johan | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2009083930A1 | Caspase-8 inhibitors and uses thereof | |
| WO2009083929A1 | Caspase-1 inhibitors and uses thereof | |
| CA2564177A1 | Caspase-2 inhibitors and their biological applications | |
| FR2860236A1 | Peptides having particularly anti-angiogenic activity and therapeutic applications thereof | |
| FR2855054A1 | Means for blocking or delaying in vitro cell death | |
| FR2850105A1 | Means for regulating the expression of human isoforms of ant |